Alzheimer’s: Tackling Scientific and Systemic Challenges to Change the Future of Alzheimer’s Care

10:15 AM - 11:15 AM (PDT), Thursday, June 16, 2022

During this session, we will provide an overview of the evolving science and AD DMT landscape, emphasizing the industry’s commitment to patients amidst decades of difficult scientific progress.  The session will also cover challenges throughout the care continuum such as access to screening and diagnosis, coverage of DMTs, patient out-of-pocket costs, and caregiver support.  Given the historical challenges with enrollment and retention of minority populations in AD clinical trials, and the broader access and affordability issues faced by those individuals, the session will also explore ways to improve equity in AD care, including industry’s efforts to improve clinical trial diversity.

Sponsored By
Moderator
photo
Editor
Neurotech Reports
Speakers
photo
Professor
University of Southern California
photo
COO
UsAgainstAlzheimer's
photo
Executive Director
Genentech, A Member of the Roche Group